<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0163945.ref029">
 <label>29</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Sulkowski</surname>
   <given-names>MS</given-names>
  </name>, 
  <name>
   <surname>Eron</surname>
   <given-names>JJ</given-names>
  </name>, 
  <name>
   <surname>Wyles</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Trinh</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Lalezari</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Wang</surname>
   <given-names>C</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial</article-title>. 
  <source>JAMA</source>. 
  <year>2015</year>;
  <volume>313</volume>(
  <issue>12</issue>):
  <fpage>1223</fpage>â€“
  <lpage>31</lpage>. 
  <pub-id pub-id-type="doi">10.1001/jama.2015.1328</pub-id> .
  <?supplied-pmid 25706092?>
  <pub-id pub-id-type="pmid">25706092</pub-id>
 </mixed-citation>
</ref>
